Smoking cessation interventions for smokers with current or past depression

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 8, 2013, Pages

  van der Meer, Regina M ^a   Willemsen, Marc C ^b,c   Smit, Filip ^d   Cuijpers, Pim ^e  

^a STIVORO   (Netherlands)

^b STIVORO Dutch Expert Centre on Tobacco Control   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SELEGILINE; SERTRALINE; NICOTINE GUM;

BEHAVIOR CHANGE; DEPRESSION; FOLLOW UP; HUMAN; META ANALYSIS; MOOD; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; SMOKING; SMOKING CESSATION; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; ADULT; DEPRESSIVE DISORDER, MAJOR; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; MAJOR DEPRESSION; METHODOLOGY; PSYCHOLOGICAL ASPECT;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DEPRESSIVE DISORDER, MAJOR; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME;

EID: 84885985838     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006102.pub2     Document Type: Review

References (203)

1. Batra A, Collins SE, Schröter M, Eck S, Torchalla I, Buchkremer G. A cluster-randomized effectiveness trial of smoking cessation modified for at-risk smoker subgroups. Journal of Substance Abuse Treatment 2010;38:128-40.
2. Collins SE, Torchalla I, Schröter M, Buchkremer G, Batra A. Development and validation of a cluster-based classification system to facilitate treatment tailoring. International Journal of Methods in Psychiatric Research 2008;17:S65-9.
3. Blondal T, Gudmundsson LJ, Tomasson K, Jonsdottir D, Hilmarsdottir H, Kristjansson F, et al. The effects of fluoxetine combined with nicotine inhalers in smoking cessation - a randomized trial. Addiction 1999;94:1007-15.
4. Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE, et al. Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology 2001;69(3):471-80.
5. Burgess ES, Brown RA, Kahler CW, Niaura R, Abrams DB, Goldstein MG, et al. Patterns of change in depressive symptoms during smoking cessation: Who's at risk for relapse?. Journal of Consulting and Clinical Psychology 2002;70(2):356-61.
6. Kahler CW, Brown RA, Ramsey SE, Niaura R, Abrams DB, Goldstein MG, et al. Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. Journal of Abnormal Psychology 2002;111(4):670-5.
7. Brown RA, Niaura R, LIoyd-Richardson EE, Strong DR, Kahler CW, Abrantes AM, et al. Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine & Tobacco Research 2007;9:721-30.
8. Carmody TP, Duncan C, Simon JA, Solkowitz S, Huggins J, Lee S, et al. Hypnosis for smoking cessation: A randomized controlled trial. Nicotine & Tobacco Research 2008;10:811-8.
9. Catley D, Ahluwalia JS, Resnicow K, Nazir N. Depressive symptoms and smoking cessation among inner-city African Americans using the nicotine patch. Nicotine & Tobacco Research 2003;5:61-8.
10. Nollen N, Ahluwalia JS, Mayo MS, Richter K, Choi WS, Okuyemi KS, et al. A randomized trial of targeted educational materials for smoking cessation in African Americans using transdermal nicotine. Health Education & Behavior 2007;34:911-27.
11. Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, Mayo MS. Sustained-release bupropion for smoking cessation in African Americans. JAMA 2002;288(4):468-74.
12. Catley D, Harris KJ, Okuyemi KS, Mayo MS, Pankey E, Ahluwalia JS. The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion. Nicotine & Tobacco Research 2005;7:859-70.
13. Cinciripini PM, Blalock JA, Minnix JA, Robinson JD, Brown VL, Lam C, et al. Effects of an intensive depression-focused intervention for smoking cessation in pregnancy. Journal of Consulting and Clinical Psychology 2010;78:44-54.
14. Covey LS, Glassman AH, Stetner F. Naltrexone effects on short-term and long-term smoking cessation. Journal of Addictive Diseases 1999;18:31-40.
15. Berlin I, Chen H, Covey LS. Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit date. Addiction 2010;105:2209-16.
16. Covey LS, Glassman AH, Stetner F, Rivelli S, Stage K. A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. American Journal of Psychiatry 2002;10:1731-7.
17. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. The Lancet 2001;357:1929-32.
18. Duffy SA, Ronis DL, Valenstein M, Lambert MT, Fowler KE, Gregory L, et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiology, Biomarkers & Prevention 2006;15:2203-8.
19. Hall SM, Muñoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. Journal of Consulting and Clinical Psychology 1994;62:141-6.
20. Hall SM, Muñoz RF, Reus VI, Sees KL, Duncan C, Humfleet GL, et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo controlled study. Journal of Consulting and Clinical Psychology 1996;64:1003-9.
21. Hall SM, Reus VI, Muñoz RF, Sees KL, Humfleet G, Hartz DT, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Archives of General Psychiatry 1998;55:683-90.
22. Tsoh JY, Humfleet GL, Muñoz RF, Reus VI, Hartz DT, Hall SM. Development of major depression after treatment for smoking cessation. American Journal of Psychiatry 2000;157:368-74.
23. Hall SM, Humfleet GL, Reus VI, Muñoz RF, Hartz DT, Maude-Griffin R. Psychological intervention and antidepressant treatment in smoking cessation. Archives of General Psychiatry 2002;59:930-6.
24. Hall SM, Tsoh JY, Prochaska JJ, Eisendrath S, Rossi JS, Redding CA, et al. Treatment for cigarette smoking among depressed mental health outpatients: A randomized clinical trial. American Journal of Public Health 2006;96:1808-14.
25. Prochaska JJ, Hall SM, Tsoh JY, Eisendrath S, Rossi JS, Redding CA, et al. Treating tobacco dependence in clinically depressed smokers: Effect of smoking cessation on mental health functioning. American Journal of Public Health 2008;98:446-8.
26. Hall SM, Humfleet GL, Muñoz RF, Reus VI, Robbins JA, Prochaska JJ. Extended treatment in older cigarette smokers. Addiction 2009;104:1043-52.
27. Hendricks PS, Delucchi KL, Hall SM. Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence. Drug and Alcohol Dependence 2010;109:114-9.
28. Borrelli B, Novak S, Hecht J, Emmons K, Papandonatos G, Abrams D. Home health care nurses as a new channel for smoking cessation treatment: Outcomes from project CARES (community-nurse assisted research and education on smoking). Preventive Medicine 2005;41:815-21.
29. Hayes RB, Dunsiger S, Borrelli B. The influence of quality of life and depressed mood on smoking cessation among medically ill smokers. Journal of Behavioral Medicine 2010;33:209-18.
30. Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT, et al. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. British Journal of Psychiatry 1999;174:173-8.
31. Hurt RD, Sachs DPL, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. The New England Journal of Medicine 1997;337(17):1195-202.
32. Kahler CW, Metrik J, LaChance HR, Ramsey SE, Abrams DB, Monti PM, et al. Addressing heavy drinking in smoking cessation treatment: A randomized clinical trial. Journal of Consulting and Clinical Psychology 2008;76:852-62.
33. Kahler CW, Spillane NS, Busch AM, Leventhal AM. Time-varying smoking abstinence predicts lower depressive symptoms following smoking cessation treatment. Nicotine & Tobacco Research 2011;13:146-50.
34. Leventhal AM, Ramsey SE, Brown RA, LaChance HR, Kahler CW. Dimensions of depressive symptoms and smoking cessation. Nicotine & Tobacco Research 2008;10:507-17.
35. Killen JD, Fortmann SP, Schatzberg A, Hayward C, Varady A. Onset of major depression during treatment for nicotine dependence. Addictive Behaviors 2003;28:461-70.
36. Killen JD, Fortmann SP, Schatzberg AF, Hayward C, Sussman L, Rohtman M, et al. Nicotine patch and paroxetine for smoking cessation. Journal of Consulting and Clinical Psychology 2000;68(5):883-9.
37. Killen JD, Fortmann SP, Schatzberg AF, Arredondo C, Murphy G, Hayward C, et al. Extended cognitive behavior therapy for cigarette smoking cessation. Addiction 2008;103:1381-90.
38. Garvey AJ, Kinunnen T, Nordstrom BL, Utman CH, Doherty K, Rosner B, et al. Effects of nicotine gum dose by level of nicotine dependence. Nicotine & Tobacco Research 2000;2:53-63.
39. Kinnunen T, Korhonen T, Garvey AJ. Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: twelve-month results of a randomized placebo controlled trial. The International Journal of Psychiatry in Medicine 2008;38:373-89.
40. Joseph AM, Nelson DB, Nugent SM, Willenbring ML. Timing of Alcohol and Smoking Cessation (TASC): smoking among substance use patients screened and enrolled in a clinical trial. Journal of Addictive Diseases 2003;22(4):87-107.
41. Joseph AM, Willenbring ML, Nugent SM, Nelson DB. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. Journal of Studies on Alcohol and Drugs 2004;65:681-91.
42. Kodl MM, Fu SS, Willenbring ML, Gravely A, Nelson DB, Joseph AM. The impact of depressive symptoms on alcohol and cigarette consumption following treatment for alcohol and nicotine dependence. Alcoholism: Clinical and Experimental Research 2008;32:92-9.
43. Levine MD, Marcus MD, Perkins KA. A history of depression and smoking cessation outcomes among women concerned about post-cessation weight gain. Nicotine & Tobacco Research 2003;5:69-76.
44. Perkins KA, Marcus MD, Levine MD, D'Amico D, Miller A, Broge M, et al. Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. Journal of Consulting and Clinical Psychology 2001;69:604-13.
45. Levine MD, Perkins KA, Kalarchian MA, Cheng Y, Houck PR, Slane JD, et al. Bupropion and cognitive behavioral therapy for weight-concerned women smokers. Archives of Internal Medicine 2010;170:543-50.
46. MacPherson L, Tull MT, Matusiewicz AK, Rodman S, Strong DR, Kahler CW, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. Journal of Consulting and Clinical Psychology 2010;78:55-61.
47. McAlister AL, Rabius V, Geiger A, Glynn TJ, Huang P, Todd R. Telephone assistance for smoking cessation: one year cost effectiveness estimations. Tobacco Control 2004;13:85-6.
48. McFall M, Saxon AJ, Malte CA, Chow B, Bailey S, Baker DG, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder. JAMA 2010;304:2485-93.
49. McFall M, Saxon AJ, Thaneemit-Chen S, Smith MW, Joseph AM, Carmody TP, et al. Integrating smoking cessation into mental health care for post-traumatic stress disorder. Clinical Trials 2007;4:178-89.
50. Muñoz RF, Marin BV, Posner SE, Perez-Stable EJ. Mood management mail intervention increased abstinence rates for Spanish speaking Latino smokers. American Journal of Community Psychology 1997;25:325-43.
51. Lenert L, Muñoz RF, Perez JE, Bansod A. Automated E-mail messaging as a tool for improving quit rates in an internet smoking cessation intervention. Journal of the American Medical Informatics Association 2004;11(4):235-40.
52. Lenert L, Muñoz RF, Stoddard J, Delucchi K, Bansod A, Skoczen S, et al. Design and pilot evaluation of an internet smoking cessation program. Journal of the American Medical Informatics Association 2003;10:16-20.
53. Muñoz RF, Lenert LL, Delucchi K, Stoddard J, Perez JE, Penilla C, et al. Toward evidence-based internet interventions: A Spanish/English Web site for international smoking cessation trials. Nicotine & Tobacco Research 2006;8:77-87.
54. Lenert L, Muñoz RF, Perez JE, Bansod A. Automated E-mail messaging as a tool for improving quit rates in an internet smoking cessation intervention. Journal of the American Medical Informatics Association 2004;11(4):235-40.
55. Lenert L, Muñoz RF, Stoddard J, Delucchi K, Bansod A, Skoczen S, et al. Design and pilot evaluation of an internet smoking cessation program. Journal of the American Medical Informatics Association 2003;10:16-20.
56. Muñoz RF, Lenert LL, Delucchi K, Stoddard J, Perez JE, Penilla C, et al. Toward evidence-based internet interventions: A Spanish/English Web site for international smoking cessation trials. Nicotine & Tobacco Research 2006;8:77-87.
57. Bränström R, Penilla C, Pérez-Stable EJ, Mũnoz RF. Positive affect and mood management in successful smoking cessation. American Journal of Health Behavior 2010;34:553-62.
58. Muñoz RF, Barrera AZ, Delucchi K, Penilla C, Torres LD, Pérez-Stable EJ. International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year. Nicotine & Tobacco Research 2009;11:1025-34.
59. Torres LD, Barrera AZ, Delucchi K, Penilla C, Pérez-Stable EJ, Muñoz RF. Quitting smoking does not increase the risk of major depressive episodes among users of Internet smoking cessation interventions. Psychological Medicine 2010;40:441-9.
60. Patten CA, Martin JE, Myers MG, Calfas KJ, Williams CD. Effectiveness of cognitive-behavioral therapy for smokers with histories of alcohol dependence and depression. Journal of Studies on Alcohol and Drugs 1998;59:327-35.
61. Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, et al. A randomized placebo controlled clinical trial of 5 smoking cessation pharmacotherapies. Archives of General Psychiatry 2009;66:1253-62.
62. Piper ME, Smith SS, Schlam TR, Fleming MF, Bittrich AA, Brown JL, et al. Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. Journal of Consulting and Clinical Psychology 2010;78:13-23.
63. Rabius V, Pike KJ, Hunter J, Wiatrek D, McAlister AL. Effects of frequency and duration in telephone counselling for smoking cessation. Tobacco Control 2007;16 Suppl 1:i71-4.
64. Rabius V, Villars P, McAlister A, Pike KJ, Wiatrek D. Telephone counseling with cognitive therapy for depression, proactive enrollment of social support and relapse prevention sessions: Effects on smokers with and without indicators of depression. American Public Health Association 135th Annual Meeting and Expo. November 6, 2007. Washington.
65. Pike KJ, Rabius V, McAlister A, Geiger A. American Cancer Society's quitLink: Randomized trial of internet assistance. Nicotine & Tobacco Research 2007;9(3):415-20.
66. Rabius V, Pike KJ, Wiatrek D. McAlister AL. Comparing internet assistance for smoking cessation: 13-month follow-up of a six-arm randomized controlled trial. Journal of Medical Internet Research 2008;10:e45.
67. Seidman DF, Westmaas JL, Goldband S, Rabius V, Katkin ES, Pike KJ, et al. Randomized controlled trial of an interactive internet smoking cessation program with long-term follow-up. Annals of Behavioral Medicine 2010;39:48-60.
68. Saules KK, Schuh LM, Arfken CL, Reed K, Kilbey MM, Schuster CR. Double-blind placebo controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive behavioral group therapy. American Journal on Addictions 2004;13:438-46.
69. Schnoll RA, Martinez E, Langer C, Miyamoto C, Leone F. Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program. Acta Oncologica 2011;50:678-84.
70. Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, et al. A bupropion smoking cessation trial for cancer patients. Cancer Causes & Control 2010;21:811-20.
71. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. The New England Journal of Medicine 1999;340:685-91.
72. Smith SS, Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston A, et al. Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Nicotine & Tobacco Research 2003;5:99-109.
73. Spring B, Doran N, Pagoto S, McChargue D, Werth Cook J, et al. Fluoxetine, smoking, and history of major depression: A randomized controlled trial. Journal of Consulting and Clinical Psychology 2007;75:85-94.
74. McClure JB, Swan GE, Catz SL, Jack L, Javitz H, McAfee T, et al. Smoking outcome by psychiatric history after behavioral and varenicline treatment. Journal of Substance Abuse Treatment 2010;38:394-402.
75. McClure JB, Swan GE, Jack L, Catz SL, Zbikowski SM, McAfee TA, et al. Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline. Journal of General Internal Medicine 2009;24:563-9.
76. Swan GE, McClure JB, Jack LM, Zbikowski SM, Javitz HS, Catz SL, et al. Behavioral counseling and varenicline treatment for smoking cessation. American Journal of Preventive Medicine 2010;38:482-90.
77. Rigotti NA, Thorndike AN, Regan S, McKool K, Pasternak RC, Chang Y, et al. Bupropion for smokers hospitalized with acute cardiovascular disease. The American Journal of Medicine 2006;119:1080-7.
78. Thorndike AN, Regan S, McKool K, Pasternak RC, Schwartz S, Torres-Finnerty N, et al. Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Archives of Internal Medicine 2008;168:186-91.
79. Van der Meer RM, Willemsen MC, Smit F, Cuijpers P, Schippers GM. Effectiveness of a mood management component as an adjunct to a telephone counselling smoking cessation intervention for smokers with a past major depression: a pragmatic randomized controlled trial. Addiction 2010;105:1991-9.
80. Vickers KS, Patten CA, Lewis BA, Clark MM, Ussher M, Ebbert JO, et al. Feasibility of an exercise counseling intervention for depressed smokers. Nicotine & Tobacco Research 2009;11:985-95.
81. King A, De Wit H, Riley RC, Cao D, Niaura R, Hatsukami D. Efficacy of naltrexone in smoking cessation: A preliminary study and an examination of sex differences. Nicotine & Tobacco Research 2006;8(5):671-82.
82. Walsh Z, Epstein A, Munisamy G, King A. The impact of depressive symptoms on the efficacy of naltrexone in smoking cessation. Journal of Addictive Diseases 2008;27:65-72.
83. Weinberger AH, George TP, McKee SA. Differences in smoking expectancies in smokers with and without a history of major depression. Addictive Behaviors 2011;36:434-7.
84. Weinberger AH, Reutenauer EL, Jatlow PI, O'Malley SS, Potenza MN, George TP. A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers. Drug and Alcohol Dependence 2010;107:188-95.
85. Wewers ME, Ferketich AK, Harness J, Paskett ED. Effectiveness of a nurse-managed, lay-led tobacco cessation intervention among Ohio Appalachian women. Cancer Epidemiology, Biomarkers & Prevention 2009;18:3451-8.
86. Aycicegi-Dinn A, Dinn W. Efficacy of an alternative smoking cessation treatment. Journal of Addictive Diseases 2011;30:368-81.
87. Bernard P, Ninot G, Guillaume S, Fond G, Courtet P, Picot MC, et al. Physical activity as a protective factor in relapse following smoking cessation in participants with a depressive disorder. The American Journal on Addictions 2012;21(4):348-55.
88. Blalock JA, Robinson JD, Wetter DW, Schreindorfer LS, Cinciripini PM. Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment. Psychology of Addictive Behaviors 2008;22:122-8.
89. Blalock JA, Lam C, Minnix JA, Karam-Hage M, Gritz ER, Robinson JD. The effect of mood, anxiety, and alcohol use disorders on smoking cessation in cancer patients. Journal of Cognitive Psychotherapy: An International Quarterly 2011;25(1):82-96.
90. Borrelli B, Niaura R, Keuthen NJ, Goldstein MG, DePue JD, Murphy C, et al. Development of major depressive disorder during smoking-cessation treatment. Journal of Clinical Psychiatry 1996;57(11):534-8.
91. Brewer JA, Mallik S, Babuscio TA, Nich C, Johnson HE, Deleone CM, et al. Mindfulness training for smoking cessation: Results from a randomised controlled trial. Drug and Alcohol Dependence 2011;119:72-80.
92. Caponnetto P, Cibella F, Mancuso S, Campagna D, Arcidiacono G, Polosa R. Effect of a nicotine-free inhalator as part of a smoking cessation programme. European Respiratory Journal 2011;38:1005-11.
93. Castro Y, Costello TJ, Correa-Fernandez V, Heppner WL, Reitzel LR, Cofta-Woerpel L, et al. Differential effects of depression on smoking cessation in a diverse sample of smokers in treatment. American Journal of Preventive Medicine 2011;41(1):84-7.
94. Chengappa KN, Kambhampati RK, Perkins K, Nigam R, Anderson T, Brar JS, et al. Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants. The Journal of Clinical Psychiatry 2001;62:503-8.
95. Blalock JA, Robinson JD, Wetter DW, Cinciripini PM. Relationship of DSM-IV-based depressive disorders to smoking cessation and smoking reduction in pregnant smokers. The American Journal on Addictions 2006;15:268-77.
96. Cinciripini PM, McClure JB, Wetter DW, Perry J, Blalock JA, Cinciripini LG, et al. An evaluation of videotaped vignettes for smoking cessation and relapse prevention during pregnancy: the Very Important Pregnant Smokers (VIPS) program. Tobacco Control 2000;9 Suppl III:iii61-3.
97. Cinciripini PM, Wetter DW, Fouladi RT, Blalock JA, Carter BL, Cinciripini LG, et al. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. Journal of Consulting and Clinical Psychology 2003;71:292-301.
98. Cornelius JR, Perkins KA, Salloum IM, Thase ME, Moss HB. Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients [letter]. Journal of Clinical Psychopharmacology 1999;19:183-4.
99. Cornelius JR, Salloum IM, Jarrett PJ, Cornelius MD, Black A, et al. Double-blind fluoxetine in depressed alcoholic smokers. Psychopharmacology Bulletin 1997;33:165-70.
100. Cox LS, Patten CA, Niaura RS, Decker PA, Rigotti N, Sachs DPL, et al. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. Journal of General Internal Medicine 2004;19:828-34.
101. Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized controlled trial. Annals of Internal Medicine 2001;135:423-33.
102. Csonka A, Jonas Z. The combination of targeted cognitive-behavioural psychotherapy and pharmacotherapy for patients suffering from depression in smoking cessation. International Journal of Neuropsychopharmacology 2008;11 Suppl 1:92.
103. Ebbert JO, Croghan IT, Sood A, Schroeder DR, Taylor Hays J, Hurt RD. Varenicline and bupropion sustained release combination therapy for smoking cessation. Nicotine & Tobacco Research 2009;11:234-9.
104. El-Mohandes AAE, El-Khorazaty MN, Kiely M, Gantz MG. Smoking cessation and relapse among pregnant African-American smokers in Washington, DC. Maternal and Child Health Journal 2011;15:S96-S105.
105. Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, et al. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorder. Journal of Clinical Psychopharmacology 2008;28:660-6.
106. Frederick SL, Hall SM, Sees KL. The effect of venlafaxine on smoking cessation in subjects with and without a history of depression. NIDA Research Monograph 1997;174:208.
107. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Comprehensive Psychiatry 1990;31:350-4.
108. Glassman AH, Stetner F, Walsh T, Raizman PS, Fleiss JL, Cooper TB, et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 1988;259:2863-6.
109. Covey LS, Glassman AH, Stetner F. Major depression following smoking cessation. American Journal of Psychiatry 1997;154:263-5.
110. Covey LS, Glassman AH, Stetner F, Becker J. Effect of history of alcoholism or major depression on smoking cessation. American Journal of Psychiatry 1993;150:1546-7.
111. Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli SK, Fleiss J, et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clinical Pharmacology and Therapeutics 1993;54:670-9.
112. Grassi MC, Enea D, Ferketich AK, Lu B, Pasquariello S, Nencini P. Effectiveness of varenicline for smoking cessation: A 1-year follow up. Journal of Substance Abuse Treatment 2011;41:64-70.
113. Kapson HS, Haaga DAF. Depression vulnerability moderates the effects of cognitive behavior therapy in a randomized controlled trial for smoking cessation. Behavior Therapy 2010;41:447-60.
114. Kinnunen T, Doherty K, Militello FS, Farvey AJ. Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement. Journal of Consulting and Clinical Psychology 1996;64(4):791-8.
115. Knekt P, Laaksonen MA, Raitasalo R, Haaramo P, Lindfors O. Changes in lifestyle for psychiatric patients three years after the start of short- and long-term psychodynamic psychotherapy and solution-focused therapy. European Psychiatry 2010;25:1-7.
116. Krishnan-Sarin S, Meandzija B, O'Malley S. Naltrexone and nicotine patch in smoking cessation: A preliminary study. Nicotine & Tobacco Research 2003;5:851-7.
117. Lerman C, Niaura R, Collins BN, Wileyto P, Audrain-McGovern J, Pinto A, et al. Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychology of Addictive Behaviors 2004;18:362-6.
118. McClure JB, Catz SL, Ludman EJ, Richards J, Riggs K, Grothaus L. Feasibility and acceptability of a multiple risk factor intervention: The step up randomized pilot trial. BMC Public Health 2011;11:167.
119. Morris CD, Waxmonsky JA, May MG, Tinkelman DG, Dickinson M, Giese AA. Smoking reduction for persons with mental illnesses: 6-month results from community based interventions. Community Mental Health Journal 2011;47:694-702.
120. Keuthen NJ, Niaura R, Borrelli B, Goldstein M, Depue J, Murphy C, et al. Comorbidity, smoking behavior and treatment outcome. Psychotherapy and Psychosomatics 2000;69:244-50.
121. Niaura R, Spring B, Borrelli B, Hedeker D, Goldstein M, Keuthen N, et al. Multicenter trial of fluoxetine as an adjunct to behavioral smoking treatment. Journal of Consulting and Clinical Psychology 2002;70:887-96.
122. O'Neil A, Hawkes AL, Chan B, Sanderson K, Forbes A, Hollingsworth B. A randomised, feasibility trial of a tele-health intervention for acute coronary syndrome patients with depression ('MoodCare'): Study protocol. BMC Cardiovascular Disorders 2011;11:8.
123. Oncken C, Cooney J, Feinn R, Lando H, Kranzler HR. Transdermal nicotine for smoking cessation in postmenopausal women. Addictive Behaviors 2007;32:296-309.
124. Parsons A, Ingram J, Inglis J, Aveyard P, Johnstone E, Brown K, et al. A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation. Drug and Alcohol Dependence 2009;102:116-22.
125. Patten CA. Treating alcoholic smokers who have a history of depression. Alcoholism: Clinical and Experimental Research 2002;26:1947-9.
126. Correa-Fernandez V, Ji L, Castro Y, Heppner L, Vidrine JI, Costello TJ, et al. Mediators of the association of major depressive syndrome and anxiety syndrome with postpartum smoking relapse. Journal of Consulting and Clinical Psychology 2012;80(4):636-48.
127. Reitzel LR, Vidrine JI, Businelle MS, Kendzor DE, Costello TJ, Yisheng L, et al. Preventing postpartum smoking relapse among diverse low-income women: A randomized clinical trial. Nicotine & Tobacco Research 2010;12(4):326-35.
128. Rennard S, Hughes J, Cinciripini PM, Kralikova E, Raupach T, Arteaga C. A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates. Nicotine & Tobacco Research 2012;14:343-50.
129. Schleicher HE, Harris KJ, Campbell DG, Harrar SW. Mood management intervention for college smokers with elevated depressive symptoms: A pilot study. Journal of American College Health 2012;60(1):37-45.
130. Reid MS, Fallon B, Sonne S, Flammino F, Nunes EV, Jiang H, et al. Smoking cessation treatment in community-based substance abuse rehabilitation programs. Journal of Substance Abuse Treatment 2008;35:68-77.
131. Sonne SC, Nunes EV, Jiang H, Tyson C, Rotrosen J, Reid MS, et al. The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers. The American Journal on Addictions 2010;19:111-8.
132. Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe, et al. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction 2008;103(1):146-54.
133. Thorndike FP, Friedman-Wheeler DG, Haaga DAF. Effect of cognitive behavior therapy on smokers' compensatory coping skills. Addictive Behaviors 2006;31:1705-10.
134. Thorsteinsson HS, Gillin C, Patten CA, Golshan S, Sutton LD, Drummond S, et al. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology 2001;24:350-8.
135. Trockel M, Burg M, Jaffe A, Barbour K, Barr Tayler C. Smoking behavior postmyocardial infarction among ENRICHD trial participants: Cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual. Psychosomatic Medicine 2008;70:875-82.
136. Vázquez FL, Becoña E. Depression and smoking in a smoking cessation programme. Journal of Affective Disorders 1999;55:125-32.
137. Williams DM, Dunsiger S, Whiteley JA, Ussher MH, Ciccolo JT, Jennings EG, et al. Acute effects of moderate intensity aerobic exercise on affective withdrawal symptoms and cravings among women smokers. Addictive Behaviors 2011;36:894-97.
138. Williams DM, Whiteley JA, Dunsiger S, Jennings EG, Albrecht AE, Ussher MH, et al. Moderate intensity exercise as an adjunct to standard smoking cessation treatment for women: a pilot study. Psychology of Addictive Behaviors 2010;24(2):349-54.
139. Yun WJ, Shin MH, Kweon SS, Ryu SY, Rhee JA. Association of smoking status, cumulative smoking, duration of smoking cessation, age of starting smoking, and depression in Korean adults. BMC Public Health 2012;12:724.
140. Ziedonis D, Harris P, Brandt P, Trudeau K, George T, Rao S, et al. Motivational enhancement therapy and nicotine replacement improve smoking cessation outcomes for smokers with schizophrenia or depression (SRNT Conference Summary). Addiction 1997;92:633.
141. Bock BC, Fava JL, Gaskins R, Morrow KM, Williams DM, Jennings E, et al. Yoga as a complementary treatment for smoking cessation in women. Journal of Women's Health 2012;21(2):240-8.
142. Bock BC, Morrow KM, Becker BM, Williams DM, Tremont G, Gaskins RB, et al. Yoga as a complementary treatment for smoking cessation: rationale, study design and participant characteristics of the quitting-in-balance study. BMC Complementary and Alternative Medicine 2010;10:14.
143. Borrelli B, McQuaid EL, Becker B, Hammond K, Papandonatos G, Fritz G, et al. Motivating parents of kids with asthma to quit smoking: the PAQS project. Health Education Research 2002;17(5):659-69.
144. Busch AM, Wagener TL, Gregor KL, Ring KT, Borrelli B. Utilizing reliable and clinically significant change criteria to assess for the development of depression during smoking cessation treatment: The importance of tracking idiographic change. Addictive Behaviors 2011;36:1228-32.
145. Campayo JG, Sobradiel N, Alda M, Mas A, Andrés E, Magallón R, et al. Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised controlled trial. BMC Family Practice 2008;9:28.
146. Carmody TP, Delucchi K, Duncan CL, Banys P, Simon JA, Solkowitz SN, et al. Intensive intervention for alcohol-dependent smokers in early recovery: A randomized trial. Drug and Alcohol Dependence 2012;122:186-94.
147. Carmody TP, Delucchi K, Simon JA, Duncan CL, Solkowitz SN, Huggins J, et al. Expectancies regarding the interaction between smoking and substance use in alcohol dependent smokers in early recovery. Psychology of Addictive Behaviors 2012;26(2):358-63.
148. Berg CJ, Cox SL, Choi WS, Mayo MS, Krebill R, Bronars CA. Assessment of depression among African American light smokers. Journal of Health Psychology 2011;17(2):197-206.
149. Cox SL, Nollen NL, Mayo MS, Choi WS, Faseru B, Benowitz NL. Bupropion for smoking cessation in African American light smokers: a randomized controlled trial. Journal of the National Cancer Institute 2012;104(4):290-8.
150. Strong DR, Taylor AN, Abrantes A, Kahler CW, Miller V, Brown RA, et al. Mood management phone counseling for smokers with recurrent depression (POS3-22). Society for Research on Nicotine and Tobacco 18th Annual Meeting. Houston, Texas, March 13-16, 2012.
151. Vidrine JI, Businelle MS, Cinciripini P, Li Y, Marcus MT, Waters AJ, et al. Associations of mindfulness with nicotine dependence, withdrawal, and agency. Substance Abuse 2009;30:318-27.
152. Waters AJ, Reitzel LR, Cinciripini P, Li Y, Marcus MT, Vidrine JI, et al. Associations between mindfulness and implicit cognition and self-reported affect. Substance Abuse 2009;30:328-37.
153. West R, Zatonski W, Cedzynska M, Lewandowska D, Pazik J, Aveyard P, et al. Placebo controlled trial of cytisine for smoking cessation. The New England Journal of Medicine 2011;365(13):1193-200.
154. Pfizer. New study with CHANTIX®/CHAMPIX® (varenicline) tablets suggests favorable benefit-risk profile in adult smokers with Major Depressive Disorder. http://www.pfizer.com/news/press_releases/pfizer_press_release.jsp?guid=2636%20at%20http://pfizer.newshq.businesswire.com&source=2012&page=1 16 October, 2012.
155. Brown RA, Abrantes A, Miller I, Niaura R, Price L, Strong D. Sequential use of fluoxetine for smokers with elevated depressive symptoms. http://clinicaltrials.gov/show/NCT00578669.
156. Brown RA, Minami H, Abrantes AM, Bloom EL, Miller IW, Niaura R, et al. Pre-quit depressive symptoms, affect and quit day cessation outcome in a randomized controlled trial of sequential fluoxetine for smokers with elevated depressive symptoms. Society for Research on Nicotine & Tobacco 19th Annual Meeting. Boston, March 2013.
157. Brown RA, Strong DR, Abrantes AM, Miller IW, Kahler CW, Niaura R. Efficacy of sequential use of fluoxetine for smoking cessation in elevated depressive symptom smokers. Society for Research on Nicotine & Tobacco 17th Annual Meeting, February 2011, Toronto.
158. Dickson-Spillmann M, Kraemer T, Rust K, Schaub M. Group hypnotherapy versus group relaxation for smoking cessation: an RCT study protocol. BMC Public Health 2012;12:271.
159. Johnson KA, Farris SG, Schmidt NB, Zvolensky MJ. Anxiety sensitivity and cognitive-based smoking processes: testing the mediating role of emotion dysregulation among treatment-seeking daily smokers. Journal of Addictive Diseases 2012;31:143-57.
160. Blalock JA, Robinson JD, Wetter DW, Schreindorfer LS, Cinciripini PM. Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment. Psychology of Addictive Behaviors 2008;22:122-8.
161. Bolam B, West R, Gunnell D. Does smoking cessation cause depression and anxiety? Findings from the ATTEMPT Cohort. Nicotine & Tobacco Research 2011;13:209-14.
162. Borrelli B. Smoking cessation: Next steps for special populations research and innovative treatments. Journal of Consulting and Clinical Psychology 2010;78:1-12.
163. Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P. Major depression and stages of smoking. A longitudinal investigation. Archives of General Psychiatry 1998;55:161-6.
164. Brown RA, Lewinsohn PM, Seeley JR, Wagner EF. Cigarette smoking, major depression, and other psychiatric disorders among adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1996;35:1602-10.
165. Brown RA, Kahler CW, Niaura R, Abrams DB, Sales SD, Ramsey SE, et al. Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology 2001;69(3):471-80.
166. Covey L. Smoking cessation among patients with depression. Primary Care 1999;26:691-706.
167. Evins AE. Treating smokers with mental illness: toward best practices. Conference SRNT Europe - Helsinki, Clinical theme lecture 2012.
168. Fergusson DM, Goodwin RD, Horwood LJ. Major depression and cigarette smoking: results of a 21-year longitudinal study. Psychological Medicine 2003;33:1357-67.
169. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: US Department Health and Human Services, 2008.
170. Gierisch JM, Bastian LA, Calhoun PS, McDuffie JR, Williams JW. Smoking cessation interventions for patients with depression: A systematic review and meta-analysis. Journal of General Internal Medicine 2012;27(3):351-60.
171. Glassman AH. Cigarette smoking: implications for psychiatric illness. The American Journal of Psychiatry 1993;150:546-53.
172. Hall SM, Muñoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. Journal of Consulting and Clinical Psychology 1994;62:141-6.
173. Hall SM, Muñoz RF, Reus VI, Sees KL, Duncan C, Humfleet GL, et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. Journal of Consulting and Clinical Psychology 1996;64:1003-9.
174. Hall SM. Nicotine interventions with comorbid populations. American Journal of Preventive Medicine 2007;33:S406-13.
175. Hall SM, Prochaska JJ. Treatment of smokers with co-occurring disorders: Emphasis on integration in mental health and addiction treatment settings. Annual Review of Clinical Psychology 2009;5:409-31.
176. Haukkala A, Utela A, Vartiainen E, McAlister A, Knekt P. Depression and smoking cessation: the role of motivation and self-efficacy. Addictive Behaviors 2000;25:311-6.
177. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-60.
178. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Wiley Blackwell, 2008.
179. Hitsman B, Moss TG, Montoya ID, George TP. Treatment of tobacco dependence in mental health and addictive disorders. The Canadian Journal of Psychiatry 2009;54:369-78.
180. Hitsman B, Papandonatos GD, McChargue DE, DeMott A, Herrera MJ, Spring B, et al. Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction 2012:294-306.
181. Hughes JR, Keeley JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swann GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine & Tobacco Research 2003;5(1):13-25.
182. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1.
183. Kahler CW, Brown RA, Ramsey SE, Niaura R, Abrams DB, Goldstein MG, et al. Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. Journal of Abnormal Psychology 2002;111(4):670-5.
184. Kalman D, Baker-Morissette S, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorder. American Journal on Addiction 2005;14:106-23.
185. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: a causal analysis. Archives of General Psychiatry 1993;50:36-43.
186. Lancaster T, Stead LF. Individual behavioural counselling. Cochrane Database of Systematic Reviews 2005, Issue 2.
187. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness. A population-based prevalence study. JAMA 2000;284:2606-9.
188. Markou A, Kenny PJ. Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotoxicity Research 2002;4:297-313.
189. Mendelsohn C. Smoking and depression. A review. Australian Family Physician 2012;41:304-7.
190. Pan W. Proactive counseling as an adjunct to minimal intervention for smoking cessation: a meta-analysis. Health Education Research 2006;21:416-27.
191. Patten CA, Martin JE, Myers MG, Calfas KJ, Williams CD. Effectiveness of cognitive-behavioral therapies for smokers with histories of alcohol dependence and depression. Journal of Studies on Alcohol 1998;59:327-35.
192. Prochaska JJ, Hall SM, Tsoh JY, Eisendrath S, Rossi JS, Redding CA, et al. Treating tobacco dependence in clinically depressed smokers: Effect of smoking cessation on mental health functioning. American Journal of Public Health 2008;98:446-8.
193. Prochaska JJ. Failure to treat tobacco use in mental health and addiction treatment settings: A form of harm reduction?. Drug and Alcohol Dependence 2010;110:177-82.
194. Ranney L, Melvin C, Lux L, McClain E, Lohr K. Systematic review: Smoking cessation intervention strategies for adults and adults in special populations. Annals of Internal Medicine 2006;145(11):845-56.
195. Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: a review. Addiction 2009;104:719-33.
196. Stead L, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews 2006, Issue 3.
197. Thorsteinsson HS, Gillin C, Patten CA, Golshan S, Sutton LD, Drummond S, et al. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology 2001;24:350-8.
198. Torres LD, Barrera AZ, Delucchi K, Penilla C, Pérez-Stable EJ, Muñoz RF. Quitting smoking does not increase the risk of major depressive episodes among users of Internet smoking cessation interventions. Psychological Medicine 2010;40:441-9.
199. Tsoh JY, Humfleet GL, Muñoz RF, Reus VI, Hartz DT, Hall SM. Development of major depression after treatment for smoking cessation. The American Journal of Psychiatry 2000;157:368-74.
200. Van der Meer RM, Willemsen MC, Smit F, Cuijpers P, Schippers GM. Effectiveness of a mood management component as an adjunct to a telephone counselling smoking cessation intervention for smokers with a past major depression: a pragmatic randomized controlled trial. Addiction 2010;105:1991-9.
201. Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA. The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population. Addiction 2012;107:1847-56.
202. Weinberger AH, Mazure CM, Morlett A, McKee SA. Two decades of smoking cessation treatment research on smokers with depression: 1990-2010. Nicotine & Tobacco Research 2013;(postprint):(postprint).
203. Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, et al. Tobacco use and cessation in psychiatric disorders: National institute of mental health report. Nicotine & Tobacco Research 2008;10:1691-715.